The vascular principle in glaucoma appears to be a scientific rationale for the applying of HBOT. On this perception, some studies reported an enhancement within the visual subject without substantial adjustments in intraocular pressure, in patients with glaucoma.OPDIVO® (nivolumab) is actually a prescription medicine utilised in combination with